A case of steroid responsive nivolumab-induced cholangitis
نویسندگان
چکیده
منابع مشابه
A case of advanced-stage sclerosing cholangitis with autoimmune pancreatitis not responsive to steroid therapy.
CONTEXT Autoimmune pancreatitis and sclerosing cholangitis associated with autoimmune pancreatitis respond well to steroid therapy. Some criteria used for the differential diagnosis of autoimmune pancreatitis and sclerosing cholangitis with autoimmune pancreatitis include the response to a steroid trial. CASE REPORT A 68-year-old woman was diagnosed as having type 3 sclerosing cholangitis wit...
متن کاملA Case of Nivolumab-Induced Myositis
Introduction TheMay2016issueofTheOncologistsummarizesU.S.Foodand Drug Administration approval for nivolumab in non-small cell lung cancer [1]. In response, we present a case of nivolumabinducedmyositis, an unlisted side effect that has been reported only once previously. Nivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. It binds to programmed cell death-1 (PD-1) and...
متن کاملA Case of Nivolumab-Induced Severe Mononeuropathy Multiplex and Rhabdomyolysis
We report an 81-year-old man with multiple liver metastases after tumorectomy for primary mediastinal malignant melanoma, who experienced limb weakness and sensory disturbance after nivolumab monotherapy. He was diagnosed with nivolumab-induced mononeuropathy multiplex and rhabdomyolysis based on serologic examination, muscle biopsy, magnetic resonance imaging of the limbs, and a nerve conducti...
متن کاملa comparison of linguistic and pragmatic knowledge: a case of iranian learners of english
در این تحقیق دانش زبانشناسی و کاربردشناسی زبان آموزان ایرانی در سطح بالای متوسط مقایسه شد. 50 دانش آموز با سابقه آموزشی مشابه از شش آموزشگاه زبان مختلف در دو آزمون دانش زبانشناسی و آزمون دانش گفتار شناسی زبان انگلیسی شرکت کردند که سوالات هر دو تست توسط محقق تهیه شده بود. همچنین در این تحقیق کارایی کتابهای آموزشی زبان در فراهم آوردن درون داد کافی برای زبان آموزان ایرانی به عنوان هدف جانبی تحقیق ...
15 صفحه اولMyasthenia Gravis Induced by Nivolumab: A Case Report
Nivolumab is a programmed cell death receptor (PD-1) inhibitor therapy for aggressive cancers; however, it poses a risk of immune-related adverse side effects. We present a 73-year-old male with renal cell carcinoma who developed myasthenia gravis (MG) after being treated with nivolumab, proven by acetylcholine receptor antibodies. Our patient presented with symptoms of fatigue and upper and lo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pathology
سال: 2021
ISSN: 0031-3025
DOI: 10.1016/j.pathol.2021.06.045